Yazarlar : Akhtar M, Waked A, Bhat H, Khalid M, Teli S, Saiful FB, Lafferty J, Bhat T.

Yayın : Future Cardiol.

Pubmed Linki : http://www.ncbi.nlm.nih.gov/pubmed/22050060

Konu : Tromboz

Literatür İçeriği :  

Abstract

In this era of very wide-spread use of percutaneous coronary intervention for the management of coronary artery disease, the appropriate duration of antiplatelet therapy after drug-eluting stent implantation still remains a subject of debate. Current recommendations from the American College of Cardiology/American Heart Association (2007) is to continue treatment with aspirin and clopidogrel for 1 year and then continue with aspirin only. However, cases of very late stent thrombosis (more than 12 months postimplantation) are being increasingly reported in literature. In this article we report a case of thrombosis as a result of drug-eluting stent placement after almost 67 months (2029 days), which to our knowledge, is the longest reported duration between the implantation of drug-eluting stent and occurrence of vascular event associated with very late stent thrombosis

Literatür Arşivi